Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,320
datasets available to search
ShareScore release 0.9.0
Dataset results
1,320 results for “Cystic fibrosis”
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
ClinicalTrials.gov study NCT03020719. IPD Sharing: NO. Countries: 1. Publications: 1.
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
ClinicalTrials.gov study NCT01349192. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of the Effect of VX-770 on Hyperpolarized Helium-3 Magnetic Resonance Imaging in Subjects With Cystic Fibrosis and the G551D Mutation
ClinicalTrials.gov study NCT01161537. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Participants With Cystic Fibrosis Who Have an F508del-CFTR Mutation
ClinicalTrials.gov study NCT02565914. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation
ClinicalTrials.gov study NCT01707290. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Neuromodulation for Children With Cystic Fibrosis Experiencing Chronic Abdominal Pain
ClinicalTrials.gov study NCT05515250. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661/Ivacaftor in Pediatric Subjects With Cystic Fibrosis (CF)
ClinicalTrials.gov study NCT02953314. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
ClinicalTrials.gov study NCT04599465. IPD Sharing: NO. Countries: 7. Publications: 1.
Blood Flow and Vascular Function in Cystic Fibrosis
ClinicalTrials.gov study NCT02057458. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age and Have an Ivacaftor-Responsive CFTR Mutation
ClinicalTrials.gov study NCT02725567. IPD Sharing: Not stated. Countries: 5. Publications: 2.
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis
ClinicalTrials.gov study NCT05090904. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age
ClinicalTrials.gov study NCT03633526. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
ClinicalTrials.gov study NCT00775528. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)
ClinicalTrials.gov study NCT00690820. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
ClinicalTrials.gov study NCT00297167. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT01807923. IPD Sharing: Not stated. Countries: 11. Publications: 7.
Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
ClinicalTrials.gov study NCT01784419. IPD Sharing: NO. Countries: 1. Publications: 1.
A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT03125395. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
ClinicalTrials.gov study NCT01519661. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis in Non-Cystic Fibrosis Patients
ClinicalTrials.gov study NCT00671723. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.